Embody vs Gala: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

53 providers verified independently·Independent research·How we rank →

Visit Embody - our pick of these two→or find your match

Embody beats Gala overall, scoring 7.3/10 vs 7.2/10. Choose Embody for people who want the oral tirzepatide gum, or who'll choose t. Choose Gala for tirzepatide-first patients who want a low-cost compounded pa.

A side-by-side look at Embody and Gala to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

Embody

#37 of 53

7.3/10

Online weight-loss program that ships compounded GLP-1 medication to your door. Run by Modern Metabolic Medicine, Inc. and prescribed through CareGLP Affiliated P.C.s, their network of licensed doctors. Two pricing plans run side by side: a promo plan starting at $99/mo for semaglutide (or $149/mo for tirzepatide) that jumps after month 1, and 'Embody Flat' at $299/mo that doesn't go up. Their standout: oral tirzepatide gum, for people who don't want to inject.

Visit Embody

Gala

#39 of 53

7.2/10

Telehealth platform focused on compounded tirzepatide, both microdose and full-dose tiers, alongside a brand-name semaglutide (Ozempic) path and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. (Wilmington, DE), backed by OpenLoop-affiliated medical groups (a recognized US telehealth backend) and LegitScript verified. Differentiator: a dedicated 'Gala GLP-1 Tracker' iOS + Android app for in-treatment dosing, weight, and side-effect logging.

Visit Gala

Feature	Embody	Gala
Our Score	7.3/10	7.2/10
Starting Price	$149/mo	$149/mo
Medication Type	Compounded	Both
Insurance Accepted	No	No
Best For	People who want the oral tirzepatide gum, or who'll choose the $299/mo 'Embody Flat' plan at signup for one predictable price	Tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated iOS + Android tracker app for daily progress logging
Watch out for	Two plans run side by side and the switchover isn't always clear at signup: the $149 promo month steps up to $299 to $399 from month 2 (Embody confirms both plans in its review replies). Pick 'Embody Flat' at signup if you want one predictable number.	Brand-name Ozempic here is $1,299/mo, materially above market (NovoCare direct pricing for Wegovy is $349/mo; Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership). Buy brand-name elsewhere, Gala's value is its compounded tirzepatide.
Ranking	#37	#39
Get started	Visit Embody	Visit Gala

Pros & Cons Compared

Embody

Pros

+Oral tirzepatide gum is rare. Real option for needle-phobic users. (How well it absorbs vs the FDA-approved injection isn't published.)
+Cheap first month, $99 for semaglutide or $149 for tirzepatide. Among the lowest entry prices in the category.
+'Embody Flat' plan is $299/mo flat with no surprise increases, predictable if you pick it from the start.
+100% money-back guarantee in writing: if you follow the program and don't see results in 6 months, they say they'll make it right.
+Replies to every negative Trustpilot review, usually within 24 hours.

Cons

−Two plans run side by side and the switchover isn't always clear at signup: the $149 promo month steps up to $299 to $399 from month 2 (Embody confirms both plans in its review replies). Pick 'Embody Flat' at signup if you want one predictable number.
−Trustpilot rating is 3.6 / 5 across 3,869 reviews, verified July 25, 2026, and 3,854 of those were left in the last 12 months. Price is the top complaint theme, most of it tied to the promo-to-flat switchover above.
−Embody doesn't name which pharmacy makes the medication, just 'multiple USA certified pharmacies.' This is the norm in the category, most major brands (Embody, Henry, Hims, Yucca, Eden) don't publicly name their pharmacy partners; ask support directly if provenance matters to you.
−No HIPAA disclosure on their site (HIPAA is the federal law protecting your medical info, most telehealth providers publish a statement confirming they follow it).
−Compounded medications only, no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic available.
−If you stop treatment and come back, Embody's doctors will likely restart you at the lowest dose (2.5mg). It's their safety policy; raise your dose history at signup, the prescriber makes the final call.

Gala

Pros

+Microdose compounded tirzepatide at $149/mo, the cheapest microdose tirz on a tracked telehealth platform; full-dose compounded tirzepatide at $179/mo (yearly plan) or $199/mo (3-month plan)
+Dedicated 'Gala GLP-1 Tracker' on BOTH iOS and Android, first-party in-treatment logging is uncommon among compounded-only platforms
+OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
+All 50 states, free shipping, no insurance required, 24/7 patient support claimed

Cons

−Brand-name Ozempic here is $1,299/mo, materially above market (NovoCare direct pricing for Wegovy is $349/mo; Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership). Buy brand-name elsewhere, Gala's value is its compounded tirzepatide.
−Tirzepatide-only on the compounded side, compounded semaglutide is NOT offered, a narrower medication menu than peers like Maximus, Ro, or Henry Meds
−Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness, verify your specific dose and batch with each refill
−Initial consultation is typically a sync video visit, but ongoing follow-ups are chat-based (no scheduled ongoing video access), and there are no published labs, no named medical director, no specialty obesity oversight
−Restrictive refund policy, Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
−Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn), limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself

Our Verdict

Embody edges out Gala with a score of 7.3/10 vs 7.2/10. Gala offers both brand-name and compounded medications, giving you more flexibility. Choose Embody if you want: people who want the oral tirzepatide gum, or who'll choose the $299/mo 'embody flat' plan at signup for one predictable price. Choose Gala if you want: tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated ios + android tracker app for daily progress logging.

Still undecided? Editor's Featured Pick

TrimRx

$149/mo · 7.8/10 · Compounded

If neither Embody nor Gala feels like the right fit, our featured pick across all 53 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.

Visit TrimRx→Read our full TrimRx review